Abstract
The development of an effective vaccine for HIV requires a better understanding of immune responses. The challenge is to contain HIV in the context of individual host genetics and the ever increasing diversity of HIV.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rosenberg, E. S. et al. Science 278, 1447–1450 (1997).
Zajac, A. J. et al. J. Exp. Med. 188, 2205–2213 (1998).
Schmitz, J. E. et al. Science 283, 857–860 (1999).
Jin, X. et al. J. Exp. Med. 189, 991–998 (1999).
Rosenberg, E. S. et al. Nature 407, 523–526 (2000).
Oxenius, A. et al. Proc. Natl Acad. Sci. USA 97, 3382–3387 (2000).
Barouch, D.H. et al. Proc. Natl Acad. Sci. USA 97, 4192–4197 (2000).
Sipsas, N. V. et al. J. Clin. Invest. 99, 752–762 (1997).
Pikora, C. A., Sullivan, J. L., Panicali, D. & Luzuriaga, K. J. Exp. Med. 185, 1153–1161 (1997).
Ray, S. C., Lubaki, N., Dhruva, B. R., Siliciano, R. F. & Bollinger, R. C. AIDS Res. Hum. Retroviruses 14, 3–13 (1998).
Jin, X. et al. AIDS Res. Hum. Retroviruses 16, 67–76 (2000).
Kuiken C. L., Foley B. T., Guzman E. & Korber B. T. in Molecular Evolution of HIV (ed. Crandall, K.) 432–468 (Johns Hopkins University Press, Baltimore, MD, 1999).
Goulder, P. J. et al. J. Virol. 74, 5679–5690 (2000).
Kaslow, R. A. et al. Nature Med. 2, 405–411 (1996).
Carrington, M. et al. Science 283, 1748–1752 (1999).
Migueles, S. A. et al. Proc. Natl Acad. Sci. USA 97, 2709–2714 (2000).
Goulder, P. J. et al. J. Exp. Med. 193, 181–194 (2001).
Kaul, R. & Rowland-Jones, S. in HIV Molecular Immunology Database Part IV (eds Korber, B. et al. ) 35–44 (Theoretical Biology and Biophysics, Los Alamos National Lab, Los Alamos, NM, 1999).
Liitsola, K. et al. AIDS 12, 1907–1919 (1998).
McCutchan, F. E. et al. AIDS Res. Hum. Retroviruses 8, 1887–1895 (1992).
Lukashov, V. V. & J. Goudsmit, J. J. Virol. 71, 6332–6338 (1997).
Vidal, N., Mulanga-Kabeya, C., Nzilambi, N., Delaporte, E. & Peeters M. AIDS Res. Hum. Retroviruses 16, 2059–2064 (2000).
Korber, B. et al. Science 288, 1789–1796 (2000).
Salemi M. et al. FASEB J. 15, 276–278 (2001).
Altfeld, M. et al. J. Exp. Med. 193, 169–180 (2001).
in HIV Molecular Immunology Database Part II B (eds Korber, B. et al. ) 1–13 (Theoretical Biology and Biophysics, Los Alamos National Lab, Los Alamos, NM, 2000). See also: http://hiv-web.lanl.gov.
Shankarappa, R. J. Virol. 7, 10489–10502 (1999).
Acknowledgements
We thank B.Gaschen and R.Thakallapally for help with the illustrations.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Walker, B., Korber, B. Immune control of HIV: the obstacles of HLA and viral diversity. Nat Immunol 2, 473–475 (2001). https://doi.org/10.1038/88656
Issue Date:
DOI: https://doi.org/10.1038/88656